ProPublica in December 2019, when Dr. Fauci wasn’t yet a household name, published its “Dollars for Profs” investigation that revealed widespread financial and other conflicts in studies financed by the National Institutes of Health. ProPublica’s findings have taken on increased significance, particularly the funding of a vaccine research nonprofit whose executive vice president had a lucrative financial stake in a biotech company with exclusive rights to his research.
The company has partnered with a Chinese biotech to launch a Covid-19 vaccine in greater China. The vaccine was approved under President Trump’s warp speed initiative.